Featured

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Drs. Jessica Fraker and Jewel Kling discuss how to determine if you are at high risk of breast cancer and how to manage that risk.

Dr. Kristina Butler, a gynecologic oncologist, offers tips for discussing gynecological health issues with a healthcare professional.

Study demonstrates potentially effective treatment for people with bladder cancer who no longer respond to Bacillus Calmette-Guérin (BCG).

Dr. Elizabeth Cathcart-Rake, a medical oncologist specializing in breast cancer, clears up confusion about who should be screened for breast cancer and when.

Surgery to treat Carole Reisinger's kidney cancer led to a colonoscopy and a second diagnosis: rectal cancer.

Dr. Janani Reisenauer, a Mayo Clinic thoracic surgeon, discusses innovation in lung cancer screening and treatment.

After a bilateral mastectomy, Kathleen Stewart opts for a new procedure to form breast mounds rather than immediate breast reconstruction.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.